{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:32:33Z","timestamp":1791639153127,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T00:00:00Z","timestamp":1389225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s12022-013-9294-3","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:31:48Z","timestamp":1389141108000},"page":"30-34","source":"Crossref","is-referenced-by-count":89,"title":["Understanding the Genetic Basis of Parathyroid Carcinoma"],"prefix":"10.1007","volume":"25","author":[{"given":"Anthony J.","family":"Gill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"9294_CR1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.22599","volume":"109","author":"PK Lee","year":"2007","unstructured":"Lee PK, Jarosek SL, Virnig BA, et al. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 109:1736-1741, 2007","journal-title":"Cancer"},{"key":"9294_CR2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1445-2197.2010.05594.x","volume":"81","author":"S Brown","year":"2011","unstructured":"Brown S, O'Neill C, Suliburk J, et al. Parathyroid carcinoma: increasing incidence and changing presentation. ANZ J Surg 81:528-32, 2011","journal-title":"ANZ J Surg"},{"key":"9294_CR3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0","volume":"31","author":"A Schantz","year":"1973","unstructured":"Schantz A, Castleman B Cancer 31:600-605, 1973","journal-title":"Cancer"},{"key":"9294_CR4","volume-title":"World Health organization classification of tumours Pathology and Genetics","author":"RA DeLellis","year":"2004","unstructured":"DeLellis RA, Lloyd RV, Heitz PU, et al. World Health organization classification of tumours Pathology and Genetics: Tumours of Endocrine Organs IARC Press Lyon 2004"},{"key":"9294_CR5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/BF00353773","volume":"18","author":"K Sandelin","year":"1994","unstructured":"Sandelin K, Tullgreen O, Farnebo LO. Clinical course of metastatic parathyroid carcinoma World J Surg 18:594-598, 1994","journal-title":"World J Surg"},{"key":"9294_CR6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/bjs.5570","volume":"94","author":"G Ippolito","year":"2007","unstructured":"Ippolito G, Palazzo FF, Sebag F, et al. Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma British Journal of Surgery 94:566-570, 2007","journal-title":"British Journal of Surgery"},{"key":"9294_CR7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem.86.2.7207","volume":"86","author":"E Shane","year":"2001","unstructured":"Shane E Clinical review 122: parathyroid carcinoma J Clin Endocrinol Metabl 86:485-493, 2001","journal-title":"J Clin Endocrinol Metabl"},{"key":"9294_CR8","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/BF01665308","volume":"15","author":"T Obara","year":"1991","unstructured":"Obara T, Fujimoto Y Diagnosis and treatment of patients with parathyroid carcinoma. An update and review. World J Surg 15:738-744, 1991","journal-title":"World J Surg"},{"key":"9294_CR9","first-page":"37","volume":"8","author":"T Ishida","year":"1991","unstructured":"Ishida T, Yokoe T, Izuo M Nationwide survey of parathyroid operations in Japan (1980-1989): Endocrine Surgery (Tokyo) 8:37, 1991","journal-title":"Endocrine Surgery (Tokyo)"},{"key":"9294_CR10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s002689900549","volume":"22","author":"G Favia","year":"1998","unstructured":"Favia G, Lumachi F, Polistina F et al. Parathyroid carcinoma: sixteen new cases and suggestions for correct management World J Surg 22:1225-1230, 1998","journal-title":"World J Surg"},{"key":"9294_CR11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01655520","volume":"10","author":"Y Fujimoto","year":"1986","unstructured":"Fujimoto Y, Obara T, Ito Y, et al. Localization and surgical resection of metastatic parathyroid carcinoma World J Surg 10:539, 1986","journal-title":"World J Surg"},{"key":"9294_CR12","first-page":"299","volume":"25","author":"RA Frayha","year":"1972","unstructured":"Frayha RA, Nassar VH, Dagher F, Salti IS. Familial parathyroid carcinoma J Med Liban 25:299-309, 1972","journal-title":"J Med Liban"},{"key":"9294_CR13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0002-9343(74)90018-7","volume":"57","author":"LE Mallette","year":"1974","unstructured":"Mallette LE, Bilezikian JP, Ketcham AS, Aurbach GD. Parathyroid carcinoma in familial hyperparathyroidism. Am J Med 57:642-8, 1974","journal-title":"Am J Med"},{"key":"9294_CR14","first-page":"315","volume":"109","author":"J Leborgne","year":"1975","unstructured":"Leborgne J, Le Neel JC, Buzelin F, Malvy P Familial cancer of the parathyroid glands. Importance of angiography in the diagnosis of regional recurrences. Considerations on 2 cases. J Chir (Paris) 109:315-26, 1975","journal-title":"J Chir (Paris)"},{"key":"9294_CR15","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/jcp.30.10.966","volume":"30","author":"JS Dinnen","year":"1977","unstructured":"Dinnen JS, Greenwoood RH, Jones JH, et al. Parathyroid carcinoma in familial hyperparathyroidism. J Clin Pathol 30:966-75, 1977","journal-title":"J Clin Pathol"},{"key":"9294_CR16","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/jcp.37.12.1370","volume":"37","author":"JF Smith","year":"1984","unstructured":"Smith JF, Coombs RGH Histological diagnosis of carcinoma of the parathyroid glandJ Clin Pathol 37:1370-137, 1984","journal-title":"J Clin Pathol"},{"key":"9294_CR17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD, Robbins Cm, Villablanca A HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome Nature Genetics 32:676-680, 2002","journal-title":"Nature Genetics"},{"key":"9294_CR18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K et al. HRPT2mutations are associated with malignancy in sporadic parathyroid tumours J Med Genet 40:657-663, 2003","journal-title":"J Med Genet"},{"key":"9294_CR19","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"T Shattuck","year":"2003","unstructured":"Shattuck T, Stiina V, Obara T et al. Somatic and Germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma New England Journal of Medicine 349:1722-1729, 2003","journal-title":"New England Journal of Medicine"},{"key":"9294_CR20","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","volume":"89","author":"F Cetani","year":"2004","unstructured":"Cetani F, Pardi E, Borsari S, et al. Genetic Analyses of HRPT2 gene in primary hyperparathyroidism: Germline and Somatic Mutations in Familial and Sporadic Parathyroid Tumours Journal of Clinical Endocrinology and Metabolism 89:5583-5591, 2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"9294_CR21","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1210\/jc.2005-0717","volume":"90","author":"L Kresbs","year":"2005","unstructured":"Kresbs L , Shattuck TM, Arnold A HRPT mutation analysis of typical sporadic parathyroid adenomas Journal of Clinical Endocrinology and Metabolism 90:5015-5017, 2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"9294_CR22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1517\/17530059.1.3.377","volume":"1","author":"DJ Marsh","year":"2007","unstructured":"Marsh DJ, Hahn MA, Howell VM, Gill AJ Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes Expert Opinion in Medical Diagnostics 1:377-92, 2007","journal-title":"Expert Opinion in Medical Diagnostics"},{"key":"9294_CR23","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","volume":"98","author":"L Bricaire","year":"2013","unstructured":"Bricaire L, Odou MF, Cardot-Bauters C, et al. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 98:E403-8, 2013","journal-title":"J Clin Endocrinol Metab."},{"key":"9294_CR24","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","volume":"10","author":"M-H Tan","year":"2004","unstructured":"Tan M-H, Morrison C, Wang P, et al. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma Clin Cancer Res 10:6629-6637, 2004","journal-title":"Clin Cancer Res"},{"key":"9294_CR25","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","volume":"30","author":"AJ Gill","year":"2006","unstructured":"Gill AJ, Clarkson A, Gimm O, et al. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and Hyperparathyroidsim-Jaw Tumor (HPT-JT) syndrome related adenomas from sporadic parathyroid adenomas and hyperplasias American Journal of Surgical Pathology 30:1140-1149, 2006","journal-title":"American Journal of Surgical Pathology"},{"key":"9294_CR26","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/bjs.5974","volume":"94","author":"GY Meyer-Rochow","year":"2007","unstructured":"Meyer-Rochow GY, Alvarado R, Sywak MS, et al. Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma British Journal of Surgery 94:1044, 2007","journal-title":"British Journal of Surgery"},{"key":"9294_CR27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","volume":"94","author":"VM Howell","year":"2009","unstructured":"Howell VM, Gill AJ, Clarkson A, et al. Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma Journal of Clinical Endocrinology and Metabolism 94:434-441, 2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"9","key":"9294_CR28","doi-asserted-by":"crossref","first-page":"e45567","DOI":"10.1371\/journal.pone.0045567","volume":"7","author":"O Wang","year":"2012","unstructured":"Wang O, Wang C, Nie M, et al. Novel HRPT2\/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas. PLoS One. 7(9):e45567, 2012","journal-title":"PLoS One."},{"key":"9294_CR29","first-page":"2895","volume":"125","author":"O Wang","year":"2012","unstructured":"Wang O, Wang CY, Shi J, et al. Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors. Chin Med J (Engl) 125:2895-901, 2012","journal-title":"Chin Med J (Engl)"},{"key":"9294_CR30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1445-5994.2011.02545.x","volume":"41","author":"S Lim","year":"2011","unstructured":"Lim S, Elston MS, Gill AJ, et al. Metastatic parathyroid carcinoma initially misdiagnosed as parathyroid adenoma: the role of parafibromin in increasing diagnostic accuracy. Intern Med J 41:695-9, 2011","journal-title":"Intern Med J"},{"key":"9294_CR31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hed.21716","volume":"34","author":"HK Kim","year":"2012","unstructured":"Kim HK, Oh YL, Kim SH, et al. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma. Head Neck 34:201-6, 2012","journal-title":"Head Neck"},{"key":"9294_CR32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12022-010-9121-z","volume":"21","author":"CC Juhlin","year":"2010","unstructured":"Juhlin CC, Nilsson IL, Johansson K, et al. Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas. Endocr Pathol 21:166-77, 2010","journal-title":"Endocr Pathol"},{"key":"9294_CR33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/ERC-07-0021","volume":"14","author":"CC Juhlin","year":"2007","unstructured":"Juhlin CC, Villablanca A, Sandelin K, et al. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. Endocr Relat Cancer. 14:501-12, 2007","journal-title":"Endocr Relat Cancer."},{"key":"9294_CR34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","volume":"156","author":"F Cetani","year":"2007","unstructured":"Cetani F, Ambrogini E, Viacava P, et al. Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur J Endocrinol 156:547-54, 2007","journal-title":"Eur J Endocrinol"},{"key":"9294_CR35","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/modpathol.2010.236","volume":"24","author":"JE Witteveen","year":"2011","unstructured":"Witteveen JE, Hamdy NA, Dekkers OM, et al. Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma. Mod Pathol. 24:688-97, 2011","journal-title":"Mod Pathol."},{"key":"9294_CR36","doi-asserted-by":"crossref","unstructured":"Caban\u00e9 T, Patricio, Gac E, et al. Detecci\u00f3n inmunohistoqu\u00edmica de parafibromina en patolog\u00eda de paratiroides. Revista chilena de cirug\u00eda, 65:20-24, 2013","DOI":"10.4067\/S0718-40262013000100004"},{"key":"9294_CR37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","volume":"35","author":"V Guarnieri","year":"2012","unstructured":"Guarnieri V, Battista C, Muscarella LA et al. CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort Cellular Oncology 35:411-422, 2012","journal-title":"Cellular Oncology"},{"key":"9294_CR38","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/2008-132-1251-PHACP","volume":"132","author":"RA DeLellis","year":"2008","unstructured":"DeLellis RA, Mazzaglia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med. 132:1251-62, 2008","journal-title":"Arch Pathol Lab Med."},{"key":"9294_CR39","unstructured":"Krujiff S, Sidhu SB, Sywak MS, et al. Negative parafibromin staining predicts malignant behaviour in atypical parathyroid adenomas Annals of Surgical Oncology Oct 1 [epub ahead of print]"},{"key":"9294_CR40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-13-0046","volume":"28","author":"F Cetani","year":"2013","unstructured":"Cetani F, Banti C, Pardi E, et al. CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. Endocr Connect. 28:186-95, 2013","journal-title":"Endocr Connect."},{"key":"9294_CR41","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.surg.2007.12.012","volume":"143","author":"MS Sarquis","year":"2008","unstructured":"M.S. Sarquis, L.G. Silveira, F.J. Pimenta, et al., Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations, Surgery 143:630\u2013640, 2008","journal-title":"Surgery"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-013-9294-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-013-9294-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-013-9294-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:11:14Z","timestamp":1647882674000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-013-9294-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,9]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["9294"],"URL":"https:\/\/doi.org\/10.1007\/s12022-013-9294-3","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,9]]}}}